Kappa opioid receptor effectors and uses thereof
US9540375B2 · kind B2 · utility
0Cited by
7References
2Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 17, 2016 |
| Grant date | Jan 10, 2017 |
| Priority date | — |
| Expiry date | May 17, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is a selective kappa opioid receptor effector, or a pharmaceutically acceptable salt thereof, useful for treating ethanol use disorder withdrawal, anxiety and/or depression, schizophrenia, mania or post-traumatic stress disorder.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.